- Home
- NVRO
NVRO
Nevro Corp.
as 01-17-2025 4:00pm EST
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 139.0M | IPO Year: | 2014 |
| Target Price: | $7.97 | AVG Volume (30 days): | 572.2K |
| Analyst Decision: | Hold | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.17 - $19.47 | Next Earning Date: | 02-19-2025 |
| Revenue: | $419,146,000 | Revenue Growth: | -0.87% |
| Revenue Growth (this year): | -3.26% | Revenue Growth (next year): | 0.64% |
Latest Nevro Corp. News
NVRO Breaking Stock News: Dive into NVRO Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand
Simply Wall St.
5 days ago
3 US Penny Stocks With Market Caps Under $200M
PR Newswire
6 days ago
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results
Zacks
25 days ago
What Makes Nevro (NVRO) a New Buy Stock
TipRanks
a month ago
Nevro price target lowered to $4.70 from $7 at Truist
MT Newswires
a month ago
Truist Securities Adjusts Price Target on Nevro to $4.70 From $7, Keeps Hold Rating
PR Newswire
a month ago
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Zacks
a month ago
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
Compare NVRO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NVRO Nevro Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.